Regulation of meprin metalloproteases in mucosal homeostasis

Ludwig Werny1, Cynthia Colmorgen1, Christoph Becker-Pauly1

  • 1Biochemical Institute, Unit for Degradomics of the Protease Web, University of Kiel, Kiel, Germany.

Insights

Meprin metalloproteases regulate the gut mucosal barrier, impacting inflammatory bowel disease (IBD). Understanding their regulation is key to developing new therapies for IBD and other inflammatory conditions.

Area of Science:

  • Gastroenterology and Immunology
  • Molecular Biology

Background:

  • The gastrointestinal tract (GIT) is lined by mucus, crucial for host-microbe symbiosis.
  • Disrupted mucosal barriers or altered mucus composition can lead to infection and inflammation.
  • Meprin metalloproteases cleave pro-inflammatory molecules and affect immune cell migration, impacting diseases like inflammatory bowel disease (IBD).

Purpose of the Study:

  • To review the regulation of meprin metalloproteases.
  • To understand the impact of meprins on mucosal homeostasis in physiological and pathological conditions.
  • To explore meprin's role in inflammatory bowel disease (IBD).

Main Methods:

  • Literature review focused on meprin metalloproteases.
  • Analysis of meprin's role in mucosal barrier function.
  • Examination of meprin's involvement in immune cell migration and inflammatory processes.

Main Results:

  • Meprin α and meprin β are identified as susceptibility genes for IBD.
  • Meprin expression is significantly downregulated in inflamed intestinal tissue compared to healthy tissue.
  • Meprin metalloproteases influence immune cell infiltration by cleaving cell adhesion and tight junction proteins.

Conclusions:

  • Meprin metalloproteases play a complex role in mucosal homeostasis and inflammation.
  • Dysregulation of meprins contributes to pathological conditions like IBD.
  • Further understanding of meprin regulation is essential for developing novel therapeutic strategies for IBD.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.7K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
663
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
971
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
699
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
787
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
815